First from left to right: Dr Milosavljevic, Russ Guidry, Elise Juge and David Beyer
Tanja Milosavljevic, M.Sci. Ph.D.
Dr. Milosavljevic joined Dr. E. Woltering`s lab in September 2008 as a Senior postdoctoral researcher and she has been managing the lab since 2011. Her responsibilities include:
- Overseing several human angiogenesis projects (sponsored by LSU Health Foundation Neuroendocrine Tumor Carcinoid Cancer Fund, Department of Surgery and Pennington Biomedical Research Center) focused on: 1. identifying the core gene set regulating the angiogenic switch in the human placental vein and inferior vena cava; 2. defining genes/signaling pathways mediating the response of the human neuroendocrine tumors to drugs and botanicals
- Developing specific protocols for DNA/RNA/protein expression analysis in neovessels grown in an in vitro human tissue-based three dimensional angiogenesis assay
- Performing and directing studies in which drugs and botanicals are evaluated for their effect on human angiogenesis in a variety of human venous and neuroendocrine tumor tissues, with an end goal of a personalized cancer patient care
- Data management and publication of scientific projects, including preparation of grants, manuscripts and abstracts.
- Educating and supervising all lab personnel (surgical residents, technicians, research associates, student workers, NIH/NCI&Novartis sponsored summer research program students) with respect to laboratory safety, equipment use, experimental design, data analysis and presentation.
Elise Juge, BS
Ms. Juge is a Research Associate in the laboratory of Dr. Eugene Woltering in the Department of Surgery, School of Medicine, LSU Health New Orleans. She graduated from Louisiana State University in Baton Rouge, LA with a bachelor of science in Biological Sciences with a minor concentration in French. She joined the research team in the spring of 2012 as a student worker while undergoing graduate studies at the University of New Orleans. In October 2013, she began working in the lab full-time. Her main duties include:
- Collection, preparation, dissection, culture, analysis, and evaluation of human tissues including but not limited to tumors, placental vessels, and inferior venae cavae.
- Performing our patented human tumor angiogenesis assay on all tumor specimens collected by our surgical team at Ochsner Medical Center in Kenner, LA. The angiogenesis data collected in the lab is one of the many tools used by our clinic physicians to determine the best care plan for each patient.
- Maintaining the neuroendocrine tumor cryopreservation tissue bank.
- Actively assisting molecular biologist, Dr. Tanja Milosavljevic, in RNA and protein extraction, preparation, and analysis. This data contributes to the many abstracts, poster presentations, and research publications written by our laboratory.
- Performing statistical analysis as well as tabular and graphical representation of large datasets.
Brianne Voros, BS
Ms. Voros joined the Department of Surgery and Dr. Woltering’s research team in August, 2016. Her duties include:
- Actively assisting the physicians & surgeons of the Neuroendocrine Tumor Program with database management and research on clinical biomarkers and radiographs.
- Composing abstracts & manuscripts to be submitted to regional and national academic conferences and surgical journals.
- Coordinating all research operations within the section’s pharmaceutical and clinical drug trials, specifically: maintaining Institutional Review Board (IRB) approval for both LSU Health Sciences IRB and Ochsner Clinical Foundation IRB, composing & submitting applications for all new pharmaceutical studies and grants, and acting as the Clinical Research Coordinator for active clinical trials held at the Neuroendocrine Tumor Program.
- Retrieving and analyzing data using eVELOS patient database, Medline and Ovid research databases and EPIC patient electronic medical record database.
- Assisting the Chairman of the American Joint Committee on Cancer (AJCC) Neuroendocrine Tumor Expert Panel in authoring new chapters on the staging of neuroendocrine tumors.